In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

For example, mutations in a gene called CYBB can disable an immune mechanism called the respiratory burst, which produces chemicals called reactive oxygen species (ROS). Despite its pulmonary ...